Bone Marrow Transplant Research Review, Issue 4

In this issue:

Safety of bloodless ASCT
Pre-transplant reduced-intensity conditioning regimens in patients with ALL
Favourable survival outcomes achieved with HLA-unrelated donor transplantation for adult patients with SAA
BeEAM conditioning prior to ASCT confers a significant delay in disease progression in mantle cell lymphoma
Poor prognosis for myeloma patients who relapse within one year of ASCT
High-dose chemotherapy plus ASCT confers durable survival outcomes in CNS lymphoma
EMN02/HO95 confirms advantage to upfront ASCT and consolidation therapy in newly diagnosed myeloma
High uric acid levels before allo-HSCT are prognostic for unfavourable outcomes
Allo-HSCT in myeloproliferative neoplasm, unclassifiable
COVID-19 in bone marrow transplant recipients

Please login below to download this issue (PDF)

Subscribe